Delivery Order SPE2DB22D1052-SPE2DB25FU9LA
- Not listed
- The Defense Logistics Agency awarded a $10,590.03 delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion...
- The Defense Logistics Agency awarded a $10.9K delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $24,188.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules in a quantity of 1,000 units, with a ceiling value of $1,441.15. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,738.42 on August 5, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules (1,000 count). This award is non-competitive and carries a firm fixed price structure with completion targeted for August 6, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, with a contract value of $13,611.53. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $2,702.16. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $1,140.59 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Tamsulosin HCL 0.4 mg, with a completion date of July 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.76 to AmerisourceBergen Drug Corp for 1,000 units of Tamsulosin HCL 0.4 mg capsules. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,412.35 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with completion scheduled for July 15, 2025. This is a firm fixed-price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9LADelivery Order
The Defense Logistics Agency awarded a $5,944.66 delivery order to AmerisourceBergen Drug Corp on June 21, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a competitive award under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor primarily supporting Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains on a competitive basis. This delivery order for Tamsulosin HCL, a medication commonly used in military and veteran healthcare systems, exemplifies the company's role in supplying essential generic pharmaceuticals and specialty medications to support federal medical supply chains worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 6/21/25 |